Cytisine

규격

485-35-8CAS 번호

207-616-0EC 번호

(1R,9S)-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-6-oneIUPAC 명칭

C11H14N2O화학식

190.24 g/mol분자량

CYTISINE; 485-35-8; Baptitoxine; Sophorine; Cytisinicline; Baptitoxin; Cytiton; Laburnin; Ulexine; Ulexin; Cytitone; Citizin; Cystisine; Cytizin; (1r,5s)-1,2,3,4,5,6-Hexahydro-8h-1,5-Methanopyrido[1,2-A][1,5]diazocin-8-One; 6039 Sopharma; citisiniclina; NSC-407282; 53S5U404NU; (1R,9S)-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-6-one; CHEBI:4055; DTXSID00883395; 1,5-Methano-8H-pyrido(1,2-a)(1,5)diazocin-8-one, 1,2,3,4,5,6-hexahydro-; (1R,9S)-7,11-diazatricyclo[7.3.1.0^{2,7}]trideca-2,4-dien-6-one; citizine; cystisin; cytisiniclinum; (1R,9S)-7,11-diazatricyclo(7.3.1.02,7)trideca-2,4-dien-6-one; (1R,9S)-7,11-diazatricyclo(7.3.1.0^(2,7))trideca-2,4-dien-6-one; (1R,5S)-1,2,3,4,5,6-hexahydro-8H-1,5-methanopyrido(1,2-a)(1,5)diazocin-8-one; TBX-Free; RefChem:54921; DTXCID501022929; 207-616-0; (-)-Cytisine; Tabex; Tsitizin; Cytisin; Tabax; MFCD00136048; (1R,5S)-3,4,5,6-Tetrahydro-1H-1,5-methanopyrido[1,2-a][1,5]diazocin-8(2H)-one; Cytisine (-); 1,5-Methano-8H-pyrido[1,2-a][1,5]diazocin-8-one, 1,2,3,4,5,6-hexahydro-, (1R,5S)-; Cytisinicline [USAN]; CHEMBL497939; 1,5-Methano-8H-pyrido(1,2-a)(1,5)diazocin-8-one, 1,2,3,4,5,6-hexahydro-, (1R,5S)-; Baphitoxine; SMR001233264; HSDB 3560; MLS003171607; EINECS 207-616-0; NSC 407282; BRN 0083882; UNII-53S5U404NU; NSC407282; C5E; Prestwick_140; (?)-Cytisine; Cytisine ((+)-); Tocris-1390; CYTISINE [HSDB]; CYTISINE [MI]; Cytisinicline (Standard); 115051-74-6; Prestwick3_000624; CYTISINE [MART.]; CYTISINICLINE [INN]; BSPBio_000588; Cytisine, >=99%, powder; 5-24-02-00535 (Beilstein Handbook Reference); MLS002153916; MLS002222174; SCHEMBL161398; CYTISINICLINE [WHO-DD]; BPBio1_000648; GTPL5347; orb1310572; orb3140155; (1R,9R)-7,11-diazatricyclo[7.3.1.0~2,7~]trideca-2,4-dien-6-one; (1S,9R)-7,11-diazatricyclo[7.3.1.0~2,7~]trideca-2,4-dien-6-one; HY-N0175R; 1,2,3,4,5,6-Hexahydro-1,5-methano-pyrido[1,2-a][1,5]diazocin-8-one (cytisine); Cytisine1,2,3,4,5,6-Hexahydro-1,5-methano-pyrido[1,2-a][1,5]diazocin-8-one; HMS2096N10; HMS2235L06; HMS3267D20; HMS3414N03; HMS3678L21; HMS3884L11; HY-N0175; MSK40318; TNP00030; BDBM50143282; EBC-09113; HB2033; PDSP1_000461; s2287; WLN: T C666 A GVN LM&TTJ; AKOS000276818; AKOS015833102; CCG-208621; DB09028; FC09851; (1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido[1,2a][1,5]diazocin-8-one; NCGC00016463-01; NCGC00016463-02; NCGC00016463-03; NCGC00016463-04; NCGC00016463-09; NCGC00017171-01; NCGC00025138-01; NCGC00025138-02; NCGC00179513-01; AC-34317; AS-19539; CAS-485-35-8; SY057153; C9779; CS-0007888; NS00067015; SW219952-1; Cytisine, >=99.0% (HPLC), >=99%; EN300-224852; F049425; Q417343; BRD-K74186897-001-02-5; BRD-K74186897-001-04-1; BRD-K74186897-001-10-8; BRD-K74186897-001-11-6; BRD-K74186897-001-12-4; BRD-K74186897-001-13-2; F9994-5373; Z1203159860; 1,2-a][1,5]diazocin-8-one, 1,2,3,4,5,6-hexahydro-; 1,2-a][1,5]diazocin-8-one, 1,2,3,4,5,6-hexahydro-, (1R)-; (1R,9S)-7,11-diazatricyclo[7.3.1.0,2,7]trideca-2,4-dien-6-one; (1R,9S)-7,11-diazatricyclo[7.3.1.0~2,7~]trideca-2,4-dien-6-one; 1,2-a][1,5]diazocin-8-one, 1,2,3,4,5,6-hexahydro-, (1R-cis)-; (1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-methano-pyrido[1,2-a][1,5]diazocin-8-one; (1R,5S)-1,2,3,4,5,6-HEXAHYDRO-1,5-METHANO-8H-PYRIDO-(1,2-A)(1,5)DIAZOCIN-8-ONE; (1R,5S)-1,2,3,4,5,6-HEXAHYDRO-8H-1,5-METHANOPYRIDO(1,2-A)(1,5)DIAZOCIN-8-ONE (CYTISINE); Citisina동의어